Gou Mizutani
Papers
1
Total Citations
12
H-Index
1
About
Gou Mizutani is a pathologist and molecular biologist whose work bridges the gap between protein expression and genetic amplification in cancer diagnostics. His primary research focuses on breast cancer biomarkers, particularly the HER2/neu oncogene, and the development of precision techniques for analyzing tumor heterogeneity. Mizutani’s most cited study, “Comparison of HER2 mRNA Amplification with Immunohistochemistry in Human Breast Cancer Using Laser Assisted Microdissection Technique” (2004, 12 citations), is a landmark methodological contribution. By employing laser-assisted microdissection to isolate pure cell populations, he demonstrated that HER2 mRNA amplification correlates strongly with immunohistochemistry (IHC) 3+ scores, but not with 2+ or 1+ scores. This work provided critical evidence that IHC alone may misclassify some patients, advocating for mRNA-level confirmation to improve trastuzumab (Herceptin) eligibility. Though his citation count is modest, Mizutani’s impact lies in refining diagnostic accuracy for targeted therapy, influencing subsequent guidelines for HER2 testing. His meticulous approach to tissue microdissection has also been applied to other cancers, underscoring his commitment to reducing false positives in clinical pathology. For students, his work exemplifies how careful technique can resolve ambiguities in cancer biomarker assessment.
Research Focus
Key Achievements
Top Papers
- 1